Home / ADAMTS13 Knockout Cell Lines

ADAMTS13 Knockout Cell Lines

Gene: ADAMTS13

Official Full Name: ADAM metallopeptidase with thrombospondin type 1 motif 13provided by HGNC

Gene Summary: This gene encodes a member of a family of proteins containing several distinct regions, including a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF). Defects in this gene are associated with thrombotic thrombocytopenic purpura. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO31228 ADAMTS13 Knockout cell line (HCT 116) Human ADAMTS13 1:2~1:4 Negative Online Inquiry
KO31229 ADAMTS13 Knockout cell line (HEK293) Human ADAMTS13 1:3~1:6 Negative Online Inquiry

Background

ADAMTS13 Gene Knockout Cell Lines are specifically engineered cellular models designed to study the ADAMTS13 gene, which encodes a metalloproteinase responsible for cleaving von Willebrand factor (VWF). This function is critical in maintaining hemostatic balance, as dysregulation can contribute to thrombotic thrombocytopenic purpura (TTP) and other coagulation disorders. These knockout cell lines completely disrupt the expression of the ADAMTS13 gene, enabling researchers to investigate the resulting physiological and pathological changes in both in vitro and in vivo systems.

The primary mechanism by which ADAMTS13 operates involves the proteolytic cleavage of ultra-large VWF multimers, preventing inappropriate platelet aggregation and thrombosis. By utilizing ADAMTS13 Gene Knockout Cell Lines, scientists can create a controlled environment to assess the effects of ADAMTS13 deficiency, uncovering the molecular pathways involved in thrombus formation and vascular health. This model is invaluable for preclinical studies aimed at developing novel therapeutic strategies for conditions arising from ADAMTS13 deficiencies.

In research settings, these cell lines provide unique advantages, including the ability to conduct gene rescue experiments, screen small-molecule inhibitors, and study the compensatory mechanisms that may arise in its absence. Additionally, they offer superior specificity and reliability compared to alternative models, such as transient knockdown approaches that lack long-term stability.

Researchers and clinicians alike will find great value in these knockout cell lines, as they facilitate a deeper understanding of thrombosis and related vascular disorders, thereby contributing to the development of targeted interventions and personalized medicine approaches. Our company prides itself on its extensive experience in cellular engineering, with a commitment to delivering high-quality, specific biological models that empower scientific research and accelerate medical advancement.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.